(-)-demecolcine increases expression ISO RGD:1321567 6480464 Demecolcine results in increased expression of GBP4 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1321567 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GBP4 mRNA CTD PMID:22079256 1,2-dichloroethane decreases expression ISO RGD:1553529 6480464 ethylene dichloride results in decreased expression of GBP3 mRNA CTD PMID:28960355 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of GBP4 mRNA CTD PMID:21983209 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of GBP4 mRNA CTD PMID:25380136 17beta-estradiol multiple interactions ISO RGD:1321567 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of GBP4 mRNA CTD PMID:30165855 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GBP4 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GBP4 mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1553529 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1553529 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of GBP4 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GBP4 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1553529 6480464 Tetrachlorodibenzodioxin affects the expression of GBP3 mRNA, Tetrachlorodibenzodioxin affects the expression of GBP4 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1553529 6480464 Tetrachlorodibenzodioxin results in decreased expression of GBP4 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1321567 6480464 Tetrachlorodibenzodioxin affects the expression of GBP4 mRNA CTD PMID:22298810 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1553529 6480464 Trinitrobenzenesulfonic Acid results in increased expression of GBP3 mRNA CTD PMID:17982090 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1553529 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of GBP3 mRNA CTD PMID:18648102 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of GBP4 mRNA CTD PMID:25380136 , PMID:30723492 4,4'-sulfonyldiphenol increases expression ISO RGD:1553529 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of GBP4 mRNA CTD PMID:33297965 4-hydroxynon-2-enal decreases expression ISO RGD:1553529 6480464 4-hydroxy-2-nonenal results in decreased expression of GBP3 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:1553529 6480464 Fenretinide results in increased expression of GBP3 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression ISO RGD:1553529 6480464 Fenretinide results in decreased expression of GBP3 mRNA CTD PMID:28973697 acetamide increases expression EXP 6480464 acetamide results in increased expression of GBP4 mRNA CTD PMID:31881176 aflatoxin B1 decreases methylation ISO RGD:1321567 6480464 Aflatoxin B1 results in decreased methylation of GBP4 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:1321567 6480464 Tretinoin results in increased expression of GBP4 mRNA CTD PMID:23830798 , PMID:33167477 antirheumatic drug decreases expression ISO RGD:1321567 6480464 Antirheumatic Agents results in decreased expression of GBP4 mRNA CTD PMID:24449571 benzo[a]pyrene decreases expression ISO RGD:1553529 6480464 Benzo(a)pyrene results in decreased expression of GBP3 mRNA CTD PMID:21569818 benzo[a]pyrene decreases methylation ISO RGD:1321567 6480464 Benzo(a)pyrene results in decreased methylation of GBP4 exon CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1553529 6480464 Benzo(a)pyrene results in increased expression of GBP3 mRNA, Benzo(a)pyrene results in increased expression of GBP4 mRNA CTD PMID:22610609 , PMID:23735875 benzo[a]pyrene increases mutagenesis ISO RGD:1321567 6480464 Benzo(a)pyrene results in increased mutagenesis of GBP4 gene CTD PMID:25435355 benzoates decreases expression ISO RGD:1321567 6480464 Benzoates analog results in decreased expression of GBP4 mRNA CTD PMID:29472718 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1553529 6480464 Diethylhexyl Phthalate results in increased expression of GBP4 mRNA CTD PMID:28085963 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GBP4 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1553529 6480464 bisphenol A results in increased expression of GBP3 mRNA CTD PMID:32156529 bisphenol A decreases expression ISO RGD:1553529 6480464 bisphenol A results in decreased expression of GBP4 mRNA CTD PMID:35598803 bisphenol A multiple interactions ISO RGD:1321567 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of GBP4 gene CTD PMID:31601247 bisphenol F increases expression ISO RGD:1553529 6480464 bisphenol F results in increased expression of GBP4 mRNA CTD PMID:30951980 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of GBP4 mRNA CTD PMID:25993096 carbon nanotube affects expression ISO RGD:1553529 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1321567 6480464 Nanotubes, Carbon results in increased expression of GBP4 mRNA CTD PMID:29348435 carbon nanotube decreases expression ISO RGD:1553529 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 CGP 52608 multiple interactions ISO RGD:1321567 6480464 CGP 52608 promotes the reaction [RORA protein binds to GBP4 gene] CTD PMID:28238834 chloroprene decreases expression ISO RGD:1553529 6480464 Chloroprene results in decreased expression of GBP3 mRNA CTD PMID:23125180 cholesterol multiple interactions ISO RGD:1553529 6480464 [Cholesterol co-treated with 1, 2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of GBP4 mRNA CTD PMID:22129739 copper atom multiple interactions ISO RGD:1321567 6480464 [Disulfiram binds to Copper] which results in increased expression of GBP4 mRNA CTD PMID:24690739 copper(0) multiple interactions ISO RGD:1321567 6480464 [Disulfiram binds to Copper] which results in increased expression of GBP4 mRNA CTD PMID:24690739 cyclophosphamide increases expression ISO RGD:1553529 6480464 Cyclophosphamide results in increased expression of GBP3 mRNA CTD PMID:15331540 cytarabine decreases expression ISO RGD:1321567 6480464 Cytarabine results in decreased expression of GBP4 mRNA CTD PMID:21198554 dibenz[a,h]anthracene increases expression ISO RGD:1553529 6480464 1 more ... CTD PMID:26377693 diclofenac increases expression ISO RGD:1553529 6480464 Diclofenac results in increased expression of GBP3 mRNA CTD PMID:26934552 dimethylarsinic acid multiple interactions ISO RGD:1553529 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GBP4 mRNA CTD PMID:34876320 dioxygen multiple interactions ISO RGD:1553529 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GBP3 mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GBP4 mRNA], [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GBP4 mRNA CTD PMID:33729688 disulfiram multiple interactions ISO RGD:1321567 6480464 [Disulfiram binds to Copper] which results in increased expression of GBP4 mRNA CTD PMID:24690739 doxorubicin decreases expression ISO RGD:1321567 6480464 Doxorubicin results in decreased expression of GBP4 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of GBP4 mRNA CTD PMID:29391264 fulvestrant multiple interactions ISO RGD:1321567 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of GBP4 gene CTD PMID:31601247 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of GBP4 mRNA CTD PMID:22061828 , PMID:33387578 lipopolysaccharide increases expression ISO RGD:1553529 6480464 Lipopolysaccharides results in increased expression of GBP3 mRNA CTD PMID:21461237 , PMID:27339419 lipopolysaccharide multiple interactions ISO RGD:1321567 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of GBP4 mRNA] CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1321567 6480464 Lipopolysaccharides results in increased expression of GBP4 mRNA CTD PMID:35811015 methyl methanesulfonate decreases expression ISO RGD:1321567 6480464 Methyl Methanesulfonate results in decreased expression of GBP4 mRNA CTD PMID:23649840 methylarsonic acid multiple interactions ISO RGD:1553529 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GBP4 mRNA CTD PMID:34876320 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of GBP4 mRNA CTD PMID:25380136 N-Nitrosopyrrolidine increases expression ISO RGD:1321567 6480464 N-Nitrosopyrrolidine results in increased expression of GBP4 mRNA CTD PMID:32234424 nickel atom increases expression ISO RGD:1321567 6480464 Nickel results in increased expression of GBP4 mRNA CTD PMID:24768652 , PMID:25583101 nickel atom decreases expression ISO RGD:1321567 6480464 Nickel results in decreased expression of GBP4 mRNA CTD PMID:23195993 nickel sulfate increases expression ISO RGD:1321567 6480464 nickel sulfate results in increased expression of GBP4 mRNA CTD PMID:22714537 oxaliplatin multiple interactions EXP 6480464 [Oxaliplatin co-treated with Topotecan] results in increased expression of GBP4 mRNA CTD PMID:25729387 ozone decreases expression ISO RGD:1553529 6480464 Ozone results in decreased expression of GBP4 mRNA CTD PMID:17095637 ozone multiple interactions ISO RGD:1553529 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GBP3 mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:1321567 6480464 Acetaminophen results in increased expression of GBP4 mRNA CTD PMID:26690555 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of GBP4 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1321567 6480464 Acetaminophen results in decreased expression of GBP4 mRNA CTD PMID:21420995 , PMID:29067470 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of GBP4 mRNA CTD PMID:32680482 PCB138 multiple interactions ISO RGD:1553529 6480464 [2 more ... CTD PMID:25510870 pentachlorophenol increases expression ISO RGD:1553529 6480464 Pentachlorophenol results in increased expression of GBP3 mRNA CTD PMID:23892564 phenobarbital affects expression ISO RGD:1553529 6480464 Phenobarbital affects the expression of GBP3 mRNA CTD PMID:23091169 pirinixic acid multiple interactions ISO RGD:1553529 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of GBP4 mRNA CTD PMID:20813756 pirinixic acid decreases expression ISO RGD:1553529 6480464 pirinixic acid results in decreased expression of GBP3 mRNA, pirinixic acid results in decreased expression of GBP4 mRNA CTD PMID:18445702 more ... potassium chromate multiple interactions ISO RGD:1321567 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GBP4 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1321567 6480464 potassium chromate(VI) results in decreased expression of GBP4 mRNA CTD PMID:22079256 progesterone decreases expression ISO RGD:1321567 6480464 Progesterone results in decreased expression of GBP4 mRNA CTD PMID:20864642 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1321567 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of GBP4 mRNA] CTD PMID:35811015 silicon dioxide increases expression ISO RGD:1553529 6480464 Silicon Dioxide results in increased expression of GBP3 mRNA CTD PMID:23221170 silver atom affects expression ISO RGD:1553529 6480464 Silver affects the expression of GBP3 mRNA CTD PMID:27131904 silver(0) affects expression ISO RGD:1553529 6480464 Silver affects the expression of GBP3 mRNA CTD PMID:27131904 sodium arsenate multiple interactions ISO RGD:1553529 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GBP4 mRNA CTD PMID:34876320 sodium arsenite increases expression ISO RGD:1553529 6480464 sodium arsenite results in increased expression of GBP3 mRNA, sodium arsenite results in increased expression of GBP4 mRNA CTD PMID:17350061 sodium arsenite multiple interactions ISO RGD:1553529 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GBP4 mRNA CTD PMID:34876320 sodium arsenite decreases expression ISO RGD:1321567 6480464 sodium arsenite results in decreased expression of GBP4 mRNA CTD PMID:34032870 sodium arsenite increases expression ISO RGD:1321567 6480464 sodium arsenite results in increased expression of GBP4 mRNA CTD PMID:22714537 sodium arsenite affects methylation ISO RGD:1321567 6480464 sodium arsenite affects the methylation of GBP4 gene CTD PMID:28589171 tamoxifen affects expression ISO RGD:1553529 6480464 Tamoxifen affects the expression of GBP4 mRNA CTD PMID:20937368 tert-butyl hydroperoxide increases expression ISO RGD:1553529 6480464 tert-Butylhydroperoxide results in increased expression of GBP3 mRNA CTD PMID:14729362 , PMID:15003993 testosterone decreases expression ISO RGD:1553529 6480464 Testosterone results in decreased expression of GBP4 mRNA CTD PMID:19693291 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GBP4 mRNA CTD PMID:32741896 tetrachloromethane increases expression ISO RGD:1553529 6480464 Carbon Tetrachloride results in increased expression of GBP3 mRNA CTD PMID:27339419 tetrachloromethane affects expression ISO RGD:1553529 6480464 Carbon Tetrachloride affects the expression of GBP4 mRNA CTD PMID:17484886 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of GBP4 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1553529 6480464 titanium dioxide results in increased expression of GBP3 mRNA CTD PMID:23557971 titanium dioxide decreases expression ISO RGD:1553529 6480464 titanium dioxide results in decreased expression of GBP4 mRNA CTD PMID:27760801 , PMID:29264374 topotecan multiple interactions EXP 6480464 [Oxaliplatin co-treated with Topotecan] results in increased expression of GBP4 mRNA CTD PMID:25729387 tremolite asbestos decreases expression ISO RGD:1553529 6480464 tremolite results in decreased expression of GBP4 mRNA CTD PMID:29279043 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of GBP4 mRNA CTD PMID:33387578 tungsten decreases expression ISO RGD:1553529 6480464 Tungsten results in decreased expression of GBP4 mRNA CTD PMID:30912803 valproic acid decreases methylation ISO RGD:1321567 6480464 Valproic Acid results in decreased methylation of GBP4 gene CTD PMID:29154799 zidovudine multiple interactions ISO RGD:1321567 6480464 [Zidovudine co-treated with IFNA1 protein] results in increased expression of GBP4 mRNA CTD PMID:20370541 zoledronic acid increases expression ISO RGD:1321567 6480464 Zoledronic Acid results in increased expression of GBP4 mRNA CTD PMID:24714768